vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
14.03
-0.46 (-3.17%)
Aug 13, 2025, 4:00 PM - Market closed
vTv Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 0.02 | 1.02 | - | 2.02 | 4.01 | 6.41 | Upgrade
|
| Revenue Growth (YoY) | -98.30% | - | - | -49.61% | -37.56% | 132.05% | Upgrade
|
| Cost of Revenue | 11.26 | 11.55 | 13.6 | 12.36 | 12.62 | 11.02 | Upgrade
|
| Gross Profit | -11.25 | -10.53 | -13.6 | -10.34 | -8.62 | -4.6 | Upgrade
|
| Selling, General & Admin | 13.25 | 13.65 | 11.91 | 12.2 | 11.44 | 7.25 | Upgrade
|
| Operating Expenses | 14.38 | 13.65 | 11.91 | 12.2 | 11.44 | 7.25 | Upgrade
|
| Operating Income | -25.62 | -24.18 | -25.5 | -22.54 | -20.06 | -11.85 | Upgrade
|
| Interest Expense | - | - | -0.01 | -0.02 | -0.01 | -0.69 | Upgrade
|
| Interest & Investment Income | 1.54 | 1.57 | 0.47 | 0.35 | 0 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.21 | 0.01 | 0.57 | 0.92 | 1.61 | -0.27 | Upgrade
|
| EBT Excluding Unusual Items | -23.87 | -22.61 | -24.47 | -21.29 | -18.46 | -12.8 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -1.6 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -1.18 | -3.59 | 2.45 | - | Upgrade
|
| Other Unusual Items | - | - | -0.31 | - | - | - | Upgrade
|
| Pretax Income | -23.87 | -22.61 | -25.97 | -24.87 | -17.62 | -12.8 | Upgrade
|
| Income Tax Expense | - | 0.1 | - | 0.2 | 0.12 | - | Upgrade
|
| Earnings From Continuing Operations | -23.87 | -22.71 | -25.97 | -25.07 | -17.73 | -12.8 | Upgrade
|
| Minority Interest in Earnings | 4.32 | 4.24 | 5.72 | 5.91 | 4.74 | 4.3 | Upgrade
|
| Net Income | -19.56 | -18.46 | -20.25 | -19.16 | -12.99 | -8.5 | Upgrade
|
| Net Income to Common | -19.56 | -18.46 | -20.25 | -19.16 | -12.99 | -8.5 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 6 | 2 | 2 | 2 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 6 | 2 | 2 | 2 | 1 | Upgrade
|
| Shares Change (YoY) | -59.13% | 176.79% | 8.60% | 22.58% | 32.90% | 55.61% | Upgrade
|
| EPS (Basic) | -7.47 | -3.20 | -9.71 | -9.98 | -8.29 | -7.21 | Upgrade
|
| EPS (Diluted) | -7.47 | -3.20 | -9.71 | -9.98 | -8.29 | -7.21 | Upgrade
|
| Free Cash Flow | -22.03 | -25.31 | -19.08 | -16.04 | -19.31 | -18 | Upgrade
|
| Free Cash Flow Per Share | -8.41 | -4.38 | -9.15 | -8.36 | -12.33 | -15.27 | Upgrade
|
| Gross Margin | - | - | - | - | -215.21% | -71.73% | Upgrade
|
| Operating Margin | -150717.65% | -2377.58% | - | -1116.95% | -500.92% | -184.78% | Upgrade
|
| Profit Margin | -115029.41% | -1815.34% | - | -949.65% | -324.27% | -132.51% | Upgrade
|
| Free Cash Flow Margin | -129558.82% | -2488.40% | - | -795.00% | -482.10% | -280.64% | Upgrade
|
| EBITDA | -25.57 | -24.09 | -25.41 | -22.45 | -19.97 | -11.76 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -183.32% | Upgrade
|
| D&A For EBITDA | 0.06 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | Upgrade
|
| EBIT | -25.62 | -24.18 | -25.5 | -22.54 | -20.06 | -11.85 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -184.78% | Upgrade
|
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.